Avaleht/Aktsiad/KMDA

KMDA

USD

Kamada Ltd. Ordinary Shares

$6.950+0.000 (0.000%)

Reaalajas hind

Healthcare

Drug Manufacturers - Specialty & Generic

Iisrael

Hinnagraafik

Loading Chart...

Põhinäitajad

Turunäitajad

Ettevõtte fundamentaalnäitajad

Kauplemisstatistika

Turunäitajad

Avatud

$6.950

Kõrge

$7.090

Madal

$6.930

Maht

0.06M

Ettevõtte fundamentaalnäitajad

Turukapitalisatsioon

403.0M

Tööstusharu

Drug Manufacturers - Specialty & Generic

Riik

Israel

Kauplemisstatistika

Keskmine maht

0.09M

Börs

NMS

Valuuta

USD

52 nädala vahemik

Madal $4.74Praegune $6.950Kõrge $9.15

Seotud uudised

15. mai 2025 · 14:39

Analyst Upgrades

Benchmark Reiterates Buy on Kamada, Maintains $15 Price Target

Benchmark analyst Robert Wasserman reiterates Kamada with a Buy and maintains $15 price target.

Vaata rohkem

Benchmark Reiterates Buy on Kamada, Maintains $15 Price Target

7. mai 2025 · 11:00

GlobeNewswire

Kamada to Announce First Quarter 2025 Financial Results on May 14, 2025

REHOVOT, Israel, and HOBOKEN, N.J., May 07, 2025 (GLOBE NEWSWIRE) -- Kamada Ltd. (NASDAQ:KMDA, TASE: KMDA.TA)), a commercial stage global biopharmaceutical company with a portfolio of marketed products indicated for

Vaata rohkem

Kamada to Announce First Quarter 2025 Financial Results on May 14, 2025

5. mai 2025 · 11:00

GlobeNewswire

Kamada Announces Launch of a Comprehensive Post-Marketing Research Program for CYTOGAM®

Program Aimed at Generating Key Data in Support of the Benefits of CYTOGAM® in the Management of Cytomegalovirus (CMV) in Solid Organ TransplantationA Total of 10 Studies will be Conducted in Collaboration with

Vaata rohkem